Lupin informs about press release

23 Nov 2023 Evaluate

Lupin has informed that it enclosed a Press release regarding launch of the world’s first fixed-dose triple combination drug under the brand name Vilfuro-G® for the effective management of chronic obstructive pulmonary disease in India. 

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2281.90 -32.95 (-1.42%)
16-Mar-2026 13:08 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1771.90
Dr. Reddys Lab 1269.60
Cipla 1297.00
Zydus Lifesciences 878.15
Lupin 2281.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×